Timothy Siegert

A scientist and entrepreneur, Tim co-founded Allyx Therapeutics upon completion of the Yale Blavatnik Fellowship for Entrepreneurship. While an inaugural Blavatnik Fellow at Yale, Tim worked within Yale OCR to build and spin out new biotech ventures from the Yale technology portfolio. Tim is a chemical biologist by training and prior to Yale held a scientist role at Ra Pharmaceuticals in Cambridge, MA. Tim holds a B.S. from Boston College and received his Ph.D. in chemistry from Tufts University.